Abstract
Type 1 diabetes is associated with high morbidity and mortality, mostly due to the acute and chronic complications of the disease. Restoration of the lost beta cell mass by pancreas transplantation is the treatment of choice in selected type 1 diabetic patients. Growing data show that successful pancreas transplantation normalizes the metabolic alterations of diabetes, and can slow the progression, stabilize, and even favor the regression of secondary complications of the disease, including those at the cardiovascular level.
Similar content being viewed by others
References
American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36:S67–S74
Di Cianni G, Benzi L, Giannarelli R, Orsini P, Villani G, Ciccarone AM, Cecchetti P, Fedele O, Navalesi R (1994) A prevalence study of known diabetes mellitus in Tuscany assessed from pharmaceutical prescriptions and other independent sources. Acta Diabetol 31:87–90
International Pancreas Transplant Registry, www.iptr.umn.edu
Boggi U, Vistoli F, Amorese G, Giannarelli R, Coppelli A, Mariotti R, Rondinini L, Barsotti M, Signori S, De Lio N, Occhipinti M, Mangione E, Cantarovich D, Del Prato S, Mosca F, Marchetti P (2012) Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients. Transplantation 93:842–846
Gremizzi C, Vergani A, Paloschi V, Secchi A (2010) Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15:119–123
Boggi U, Rosati CM, Marchetti P (2013) Follow-up of secondary diabetic complications after pancreas transplantation. Curr Opin Organ Transplant 18:102–110
Occhipinti M, Rondinini L, Mariotti R, Scelza N, Barsotti M, Vistoli F, Amorese G, Boggi U, Marchetti P (2012) Cardiac morphology and function in type 1 diabetic patients with successful pancreas transplant alone. Diabetologia 55(suppl 1):S68
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marchetti, P., Occhipinti, M., Rondinini, L. et al. Metabolic and cardiovascular effects of beta cell replacement in type 1 diabetes. Intern Emerg Med 8 (Suppl 1), 55–56 (2013). https://doi.org/10.1007/s11739-013-0912-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-013-0912-3